PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 247 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $359,433 | +33.0% | 27,025 | +15.8% | 0.00% | – |
| Q1 2023 | $270,196 | +141363.9% | 23,333 | 0.0% | 0.00% | – |
| Q4 2022 | $191 | -99.7% | 23,333 | +88.2% | 0.00% | – |
| Q3 2022 | $72,000 | +30.9% | 12,400 | 0.0% | 0.00% | – |
| Q2 2022 | $55,000 | -95.4% | 12,400 | -90.5% | 0.00% | -100.0% |
| Q1 2022 | $1,190,000 | -55.5% | 130,720 | 0.0% | 0.00% | -66.7% |
| Q4 2021 | $2,675,000 | -84.4% | 130,720 | -80.5% | 0.00% | -84.2% |
| Q3 2021 | $17,097,000 | – | 669,160 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |